Missing/wrong data?
Log in to edit
A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial
scientific article published on 28 February 2020
Author/s
author: Ewa Lech-Marańda, Sebastian Grosicki, Tadeusz Robak, Janusz Kłoczko, Jerzy Z. Blonski, Javier Loscertales, Justyna Rybka
Work details
Publication date
February 28, 2020
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.